{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:47:53Z","timestamp":1787024873228,"version":"build-2736575974"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["RPCN"],"published-print":{"date-parts":[[2010,6,1]]},"DOI":"10.2174\/157488910791213130","type":"journal-article","created":{"date-parts":[[2010,5,3]],"date-time":"2010-05-03T19:44:51Z","timestamp":1272915891000},"page":"109-117","source":"Crossref","is-referenced-by-count":84,"title":["Incretin Analogues that have been Developed to Treat Type 2 Diabetes Hold Promise as a Novel Treatment Strategy for Alzheimers Disease"],"prefix":"10.2174","volume":"5","author":[{"given":"Christian","family":"Holscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Recent Patents on CNS Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/86073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T09:28:40Z","timestamp":1448270920000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1574-8898&volume=5&issue=2&spage=109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,1]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/157488910791213130","relation":{},"ISSN":["1574-8898"],"issn-type":[{"value":"1574-8898","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6,1]]}}}